After a nearly 15-fold rise in value in the previous session, shares of Bright Minds Biosciences (NASDAQ:DRUG) fell ~29% on ...

The oldsters think marijuana is still about 2% to 3% THC. Maybe when they were listening to the Beatles' "White Album" in ...

To our knowledge, this is the first study testing the relationships of IPV-related PTSD, drug problems, and alcohol problems with sexual risk behavior among women experiencing IPV. Findings ...

Alzamend Neuro Announces Full Data Set from Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s ...

A retired Georgia Navy veteran faces drug trafficking charges in Dubai after being arrested for possessing medically prescribed CBD pills.

As at-home, DIY brain stimulation devices gain popularity for common psychiatric disorders, questions arise about their ...

With millions of Americans taking GLP-1 medications for weight loss, the thought of taking one of these medications might ...

While some studies suggest that 3,4-methyl​enedioxy​methamphetamine (MDMA)-assisted therapy can reduce symptoms (PTSD) in ...

It’s estimated that 63% of people in jail and 58% of those in prison struggle with a substance use disorder. Most go ...

When you think of brain stimulating medtech, startups building wearables as therapeutics probably aren't the first thing that ...

Bright Minds Biosciences (NASDAQ: DRUG), a little-known biotech company, became the talk of the market yesterday after its ...

Graft Polymer (UK) plc has announced a research agreement between its partner, Awakn Life Sciences Corp., and the University of Nottingham. The agreement covers in vivo research to evaluate the ...